Clariness and SubjectWell announced their merger to form one of the largest global, full-service patient recruitment platforms, combining global scale, scientific rigor, and patient-first design to transform clinical trial access and execution worldwide. The transaction was led by WindRose Health Investors, LLC (“WindRose”), which previously acquired SubjectWell in April 2024. “The combination of these two businesses under the Clariness brand creates a category-defining patient recruitment platform that is powered by innovation, data, and technology,” said CJ Burnes, a Partner at WindRose. “Clariness’ and SubjectWell’s technology and breadth of capabilities bring much needed speed and efficiency to clinical research, delivering significant value to customers.”
Read the full article: Clariness and SubjectWell Merge to Form Global, Full-Service Patient Recruitment Platform //
Source: https://www.prnewswire.com/news-releases/clariness-and-subjectwell-merge-to-form-global-full-service-patient-recruitment-platform-302670793.html